Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Histol Histopathol ; 24(7): 879-91, 2009 07.
Article in English | MEDLINE | ID: mdl-19475534

ABSTRACT

Tumorigenesis in human glioblastoma multiforme (GBM) is driven by several genetic abnormalities with disruption of important molecular pathways, such as p53/MDM2/p14ARF and EGFR/PTEN/Akt/mTOR. The malignant progression of human GBM is also primarily associated with a peculiar multistep pathophysiological process characterized by intratumoral ischemic necrosis (i.e. pseudopalisading necrosis) and activation of the hypoxia-inducible factor (HIF)-1alpha pathway with consequent peritumoral microvascular proliferation and infiltrative behaviour. Predictable preclinical animal models of GBM should recapitulate the main pathobiological hallmarks of the human disease. In this study we describe two murine orthotopic xenograft models using U87MG and U251 human cell lines. Ten Balb/c nude male mice were orthotopically implanted with either U87MG (5 mice) or U251 (5 mice) cell lines. Intracranial tumor growth was monitored through Magnetic Resonance Imaging (MRI). Immunohistopathological examination of the whole cranium was performed 30 days after implantation. U251 orthotopic xenografts recapitulated the salient pathobiological features described for human GBM, including invasive behaviour, wide areas of pseudopalisading necrosis, florid peripheral angiogenesis, GFAP and vimentin expression, nonfunctional p53 expression, striking active-caspase-3 and HIF-1alpha expression along pseudopalisades. U87MG orthotopic xenografts proved to be very dissimilar from human GBM, showing expansile growth, occasional necrotic foci without pseudopalisades, intratumoral lacunar pattern of angiogenesis, lack of GFAP expression, functional p53 expression and inconsistent HIF-1alpha expression. Expression of pAkt was upregulated in both models. The results obtained suggest that the U251 orthotopic model may be proposed as a predictive and reliable tool in preclinical studies since it recapitulates the most salient pathobiological features reported for human GBM.


Subject(s)
Brain Neoplasms , Glioblastoma , Immunohistochemistry , Magnetic Resonance Imaging , Xenograft Model Antitumor Assays/methods , Animals , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Line, Tumor , Disease Models, Animal , Glioblastoma/diagnostic imaging , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Mice , Mice, Nude , Neoplasm Transplantation , Radiography
2.
G Ital Nefrol ; 24 Suppl 38: 33-8, 2007.
Article in Italian | MEDLINE | ID: mdl-17922445

ABSTRACT

BACKGROUND: In the C. Poma Hospital of Mantua we have been using a system of continuous surveillance of nosocomial infections based on microbiological data for the past 4 years. This monitoring estimates the incidence of the microorganisms found in cultures, especially those at risk of causing nosocomial infections. MATERIALS AND METHODS: Since June 2001 microbiological data have been registered using the Mercurio-Dianoema software and elaborated by means of Microsoft Excel in order to obtain information about isolated bacteria, especially those resistant to antibiotics. RESULTS: Surveillance in "critical" wards revealed the presence of Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans in the intensive care unit in the period 2003-2005. The most frequent bacteria in hemodialysis have been coagulase-negative Staphylococci and Staphylococcus aureus, with variable methicillin resistance. CONCLUSION: The analysis of microbiological data has promoted effective measures to reduce the incidence of these bacteria (increased rules of good practice, hand washing, etc.). If nosocomial infections or high-risk microorganisms occur, assessments are carried out; monitoring of the antibiotic resistance of the bacteria is very important.


Subject(s)
Candidiasis/prevention & control , Cross Infection/prevention & control , Intensive Care Units , Population Surveillance , Pseudomonas Infections/prevention & control , Staphylococcal Infections/prevention & control , Candidiasis/epidemiology , Candidiasis/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Humans , Incidence , Italy/epidemiology , Microbial Sensitivity Tests , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/isolation & purification , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification
3.
Infez Med ; 14(2): 85-91, 2006 Jun.
Article in Italian | MEDLINE | ID: mdl-16891853

ABSTRACT

For the period 2002-2005 we verified and compared the data of the prevalence and resistance of Pseudomonas aeruginosa (PA) isolated in Mantova Hospital (Italy) with the data from the international database. From the first six-month period of 2004 a significant increase was found (9% vs 28.8%) in the prevalence of multi-drug resistant PA (MDR-PA). The principal wards involved were the Intensive Care Unit and the Department of Respiratory Diseases. A significant increase in resistance rates was observed for all antimicrobials tested, in particular for aztreonam, ceftazidime, ciprofloxacin, gentamycin and imipenem. The lowest dual resistance rates were observed between amikacina with piperacillin/tazobactam, while the highest were for those that included ciprofloxacin and beta-lactams (aztreonam, cefepime). In this study we confirm the importance of continuous surveillance of laboratory data and tightening local control measures for nosocomial infections in order to prevent the spread and selection of MDR-PA.


Subject(s)
Cross Infection/microbiology , Drug Resistance, Multiple, Bacterial , Population Surveillance , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Body Fluids/microbiology , Cross Infection/epidemiology , Cross Infection/prevention & control , Hospital Departments/statistics & numerical data , Hospitals, Urban/statistics & numerical data , Humans , Italy/epidemiology , Prospective Studies , Pseudomonas Infections/epidemiology , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa/isolation & purification
5.
Vet Clin Pathol ; 35(1): 24-30, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16511787

ABSTRACT

BACKGROUND: Fine-needle aspiration cytology (FNAC) is commonly used as a diagnostic procedure to evaluate superficial and deep masses in animals. However, few studies have addressed the accuracy of FNAC in the evaluation of cutaneous and subcutaneous masses in a clinical setting. OBJECTIVE: The purpose of this study was to compare the accuracy of FNAC as compared with histopathology in the diagnosis of cutaneous and subcutaneous masses from dogs and cats. METHODS: Cytologic and histopathologic specimens obtained between 1999 and 2003 from 292 palpable cutaneous and subcutaneous masses obtained from 242 dogs and 50 cats were retrospectively evaluated. Cytologic samples were obtained by FNA and histopathologic samples were collected by surgical biopsy or at necropsy. Concordance was determined and the accuracy of FNAC for the diagnosis of neoplasia was determined using histopathology as the gold standard. RESULTS: Of 292 specimens, 49 (from 44 dogs and 5 cats) were excluded due to poor cellularity of the cytologic specimen (retrieval rate 83.2%, n = 243). A cytologic diagnosis of neoplasia was obtained in 176 cases (175 true positives and 1 false positive compared with histopathology). Sixty-seven cytology samples were classified as non-neoplastic (46 true negatives, 21 false negatives compared with histopathology). Overall, the cytologic diagnosis was in agreement with the histopathologic diagnosis in 90.9% (221/243) of cases. For diagnosing neoplasia, cytology had a sensitivity of 89.3%, a specificity of 97.9%, a positive predictive value of 99.4%, and a negative predictive value of 68.7%. CONCLUSIONS: The results of this study confirmed FNAC as a reliable and useful diagnostic procedure for the evaluation of palpable cutaneous and subcutaneous lesions in small animal practice.


Subject(s)
Biopsy, Fine-Needle/veterinary , Cat Diseases/diagnosis , Dog Diseases/diagnosis , Neoplasms/veterinary , Skin Neoplasms/veterinary , Animals , Cat Diseases/pathology , Cats , Dog Diseases/pathology , Dogs , False Negative Reactions , False Positive Reactions , Neoplasms/diagnosis , Neoplasms/pathology , Predictive Value of Tests , Retrospective Studies , Sensitivity and Specificity , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology
6.
J Chemother ; 16(5): 494-6, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15565919

ABSTRACT

In the last decade, a remarkable increase in the incidence of nosocomial Gram-negative infections has been observed. These pathogens represent a substantial problem in clinical practice, due to the high resistance profile of most commonly used antibiotics. This phenomenon is surely a co-factor that exposes these susceptible patients to infections caused by selected pathogens like multiresistant Gram-negative rods. A typical example is represented by VAP (ventilator-associated pneumonia) sustained by Acinetobacter spp., Pseudomonas aeruginosa, Bulkolderia cepacia. The Authors describe a case of a central venous cather (CVC)-related Stenotrophomonas maltophilia sepsis in a patient affected by solid tumor, successfully treated with systemic antibiotic therapy associated with "lock therapy". This combination was able to cure the infection, allowing the patient to continue chemotherapy and saving the in situ CVC. The surveillance of CVCs, good adherence to the protocols and guidelines and "good practice" are the cornerstones for the prevention of nosocomial infections.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacteremia/drug therapy , Drug Resistance, Bacterial , Gram-Negative Bacterial Infections/drug therapy , Stenotrophomonas maltophilia/drug effects , Teicoplanin/administration & dosage , Bacteremia/diagnosis , Bacteremia/etiology , Bacteremia/pathology , Catheterization, Central Venous/adverse effects , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/etiology , Cross Infection/pathology , Diagnosis, Differential , Drug Administration Schedule , Equipment Contamination , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/etiology , Gram-Negative Bacterial Infections/pathology , Humans , Male , Microbial Sensitivity Tests , Middle Aged
7.
Lupus ; 12(1): 46-51, 2003.
Article in English | MEDLINE | ID: mdl-12587826

ABSTRACT

T cells from patients with systemic lupus erythematosus (SLE) display antigen receptor-mediated signaling aberrations associated with defective T cell receptor (TCR) zeta chain expression. We determined the prevalence of TCR zeta chain deficiency in SLE from a large cohort of unselected racially diverse patients with different levels of clinical disease activity as determined by SLE Disease Activity Index (SLEDAI). Our data show that the occurrence of TCR zeta chain deficiency is 78% in SLE patients. There was no relationship between the deficiency of TCR zeta chain and the SLEDAI scores or theapy. TCR zeta chain deficiency was also not associated with age, race or gender and persisted over a 3 year follow-up period. Thus, there is a high prevalence of TCR zeta chain deficiency in SLE patients that is independent of disease activity, and persists over time indicating an important role for TCR zeta chain deficiency in SLE pathogenesis.


Subject(s)
Lupus Erythematosus, Systemic/epidemiology , Lupus Erythematosus, Systemic/immunology , Membrane Proteins/deficiency , Receptors, Antigen, T-Cell/deficiency , Adult , Aged , Female , Humans , Lupus Erythematosus, Systemic/therapy , Male , Middle Aged , Prevalence , Severity of Illness Index , Signal Transduction/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
8.
Oncogene ; 20(50): 7293-300, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11704858

ABSTRACT

Tumor neovascularization is controlled by a balance between positive and negative effectors, whose production can be regulated by oncogenes and tumor suppressor genes. The aim of this study was to investigate whether the angiogenic potential of tumors could also be controlled by p73, a gene homologous to the tumor suppressor p53, whose involvement in tumor angiogenesis is known. We have studied the production of proangiogenic (VEGF, FGF-2, PIGF and PDGF) and antiangiogenic (TSP-1) factors in two p73 overexpressing clones obtained from the human ovarian carcinoma cells A2780. TSP-1 was downregulated in both clones compared to mock transfected cells, both at mRNA and protein level. Conversely, both clones showed an increased production of VEGF mRNA and protein. For both TSP-1 and VEGF, regulation of expression was partially due to modulation of the promoter activity, and was dependent on p53 status. Production of the other angiogenic factors FGF-2, PIGF and PDGF-B was also increased in p73 overexpressing clones. The two clones were more angiogenic than parental cells, as shown in vitro by their increased chemotactic activity for endothelial cells, and in vivo by the generation of more vascularized tumors. These findings suggest a potential role of p73 in tumor angiogenesis.


Subject(s)
DNA-Binding Proteins/physiology , Endothelial Growth Factors/biosynthesis , Lymphokines/biosynthesis , Neovascularization, Pathologic/genetics , Nuclear Proteins/physiology , Thrombospondin 1/biosynthesis , Animals , Blotting, Northern , Carcinoma/pathology , Chemotaxis/drug effects , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/pharmacology , Culture Media, Serum-Free , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Endothelial Growth Factors/genetics , Endothelium, Vascular/cytology , Enzyme-Linked Immunosorbent Assay , Female , Fibroblast Growth Factor 2/biosynthesis , Fibroblast Growth Factor 2/genetics , Gene Expression Regulation, Neoplastic , Genes, Tumor Suppressor , Genes, p53 , Humans , Lymphokines/genetics , Membrane Proteins , Mice , Mice, Nude , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Transplantation , Neoplasms, Experimental/blood supply , Neovascularization, Pathologic/metabolism , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , Ovarian Neoplasms/pathology , Platelet-Derived Growth Factor/biosynthesis , Platelet-Derived Growth Factor/genetics , Promoter Regions, Genetic , Protein Biosynthesis , Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Neoplasm/biosynthesis , Recombinant Fusion Proteins/physiology , Reverse Transcriptase Polymerase Chain Reaction , Thrombospondin 1/genetics , Transfection , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Protein p73 , Tumor Suppressor Protein p53/physiology , Tumor Suppressor Proteins , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
10.
Cancer Gene Ther ; 8(7): 491-6, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11498770

ABSTRACT

The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally or systemically, in mice transplanted with melanoma cells. The treatment reduced melanoma growth by 50% to 90% compared to that occurring in control animals treated with liposome-coated plasmid carrying the lacZ gene or in untreated controls. The growth of both locally injected and controlateral uninjected tumors in mice bearing two melanoma grafts was significantly suppressed after intratumoral treatment. Tumor growth inhibition was also observed in mice treated by intraperitoneal delivery, suggesting that angiostatin gene therapy acts through a systemic effect. Both melanoma growth suppression and delay in the onset of tumor growth were observed in treated mice. PCR performed on tumors and normal tissues showed that the lipofected DNA was present in tissues from treated mice, and angiostatin expression was demonstrated by RT-PCR. Histopathological analysis of melanoma nodules revealed an increase in apoptotic cells and a reduction in vessel density in tumors from treated mice. Our results suggest that systemic, liposome-mediated administration of genes coding for antiangiogenic factors represents a promising strategy for melanoma treatment in humans.


Subject(s)
Genetic Therapy/methods , Melanoma/therapy , Peptide Fragments/genetics , Plasminogen/genetics , Angiostatins , Animals , Cell Division , DNA/metabolism , DNA, Complementary/metabolism , Humans , Lac Operon/genetics , Liposomes/metabolism , Mice , Mice, Nude , Neoplasm Transplantation , Neovascularization, Pathologic , Peptide Fragments/biosynthesis , Plasminogen/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Tumor Cells, Cultured
11.
Article in English | MEDLINE | ID: mdl-11393820

ABSTRACT

Forty-seven wild brown rats (Rattus norvegicus) collected from the urban area of Milan (Italy) were screened for Capillaria hepatica liver infection. The liver of each rat was grossly and histologically examined for the presence of C. hepatica adults, eggs and typical C. hepatica induced lesions. In 17 rats (36%) liver lesions consistent with C. hepatica infection were detected. Grossly, white-yellow nodules of 1-5 mm in diameter were present, either scattered on the liver surface or localized in a single lobe. Histologically, granulomatous liver lesions associated with eggs and/or worms were observed. The degree of gross liver involvement was moderate in most of the positive cases (71%). About 30 cases of C. hepatica infection in humans have been documented world-wide, most of which are reported in children from 1 to 5 years of age. Our results suggest that the potential transmission of C. hepatica to children in the study area should be considered an important health issue.


Subject(s)
Capillaria/isolation & purification , Enoplida Infections/veterinary , Rodent Diseases/epidemiology , Animals , Animals, Wild , Disease Reservoirs , Enoplida Infections/epidemiology , Humans , Italy/epidemiology , Liver/parasitology , Prevalence , Rats , Rodent Diseases/parasitology , Urban Health
12.
Gene Ther ; 8(1): 67-70, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11402303

ABSTRACT

Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.


Subject(s)
Adenocarcinoma/therapy , Angiogenesis Inhibitors/genetics , Genetic Therapy/methods , Mammary Neoplasms, Experimental/therapy , Neovascularization, Pathologic/prevention & control , Adenocarcinoma/blood supply , Adenocarcinoma/pathology , Adenocarcinoma/secondary , Animals , Female , Humans , Liposomes , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Mammary Neoplasms, Experimental/blood supply , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Transgenic
13.
Comp Med ; 50(5): 536-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11099138

ABSTRACT

Ringtail is a pathologic condition of the tail of rats and other rodents that is traditionally attributed to low environmental humidity, although dietary deficiencies, genetic susceptibility, environmental temperature, and degree of hydration of the animal also have been suggested as possible causes. To the authors' knowledge, a detailed histopathologic study that may serve to shed light on the etiopathogenesis of this disease has not yet been published. We describe the histologic findings of ringtail observed in 12 suckling Munich Wistar Fromter (MWF) rats from two litters. Epidermal hyperplasia characterized by orthokeratotic and parakeratotic hyperkeratosis and acanthosis was observed in all affected rats. Numerous often dilated vessels were present in the dermis of tails that appeared of red/brown color at gross examination. In severe cases, the dilated vascular structures were thrombotic and accompanied by dermal hemorrhages and focal coagulative necrosis of the overlying epidermis. These findings suggest that epidermal acanthosis and hyperkeratosis are the main and primary events in the development of ringtail. To clarify the cause of this disease, future studies should be focused on the numerous factors that can induce such epidermal changes.


Subject(s)
Dietary Proteins/administration & dosage , Rats, Wistar/physiology , Rodent Diseases/pathology , Skin Diseases/veterinary , Tail/pathology , Animals , Animals, Suckling , Female , Histocytochemistry/veterinary , Male , Rats , Rodent Diseases/etiology , Skin Diseases/etiology , Skin Diseases/pathology
15.
Exp Cell Res ; 258(2): 384-94, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10896789

ABSTRACT

Matrix metalloproteinases (MMPs) play a critical role in the development of hemangioma-like vascular tumors in mice injected with murine eEnd.1 endothelioma cells. The current study was designed to (a) characterize the presence of MMPs in the vascular tumor, (b) define whether these MMPs originate from the transformed cells or from the recruited stromal cells and (c) study the stimulatory effect of eEnd.1 cells on the production of MMPs by endothelial cells. Several gelatinases were present in the eEnd.1 tumor extract, including latent and activated MMP-2 (72-kDa gelatinase A, EC 3.4.24. 24) and MMP-9 (92-kDa gelatinase B, EC 3.4.24.35). Immunohistochemical analysis of the tumor revealed focal reactivity for MMP-2. No gelatinase was produced by cultured eEnd.1 cells, or by six of nine related endothelioma cell lines, suggesting that stroma cells, particularly endothelial cells recruited by the tumor cells, rather than eEnd.1 cells themselves, are the source of the gelatinases observed in the tumors in vivo. The conditioned medium of eEnd.1 cells stimulated the release of MMP-2 and MMP-1 (interstitial collagenase, EC 3.4.24.7) by endothelial cells, but not of the inhibitor TIMP-2. The increased production of MMP-2 and MMP-1, observed at the protein level (zymogram and Western blot analysis), occurred through a posttranscriptional mechanism, since no increase in mRNA was observed and the stimulation was not prevented by inhibitors of protein synthesis. The inhibitory effects of monensin and brefeldin A, inhibitors of protein secretion, and the decrease in cell-associated MMP-2 in stimulated endothelial cells indicated that regulation occurred mostly at the level of protease secretion. MMPs are known to be regulated at different levels; this study indicates that, in endothelial cells, the stimulation of MMPs can also occur at the level of secretion, a mechanism that provides a rapid mobilization of these crucial enzymes in the early phases of angiogenesis.


Subject(s)
Endothelium, Vascular/enzymology , Hemangioma/enzymology , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 2/metabolism , Animals , Cell Line, Transformed , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Hemangioma/metabolism , Humans , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 9/biosynthesis , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/biosynthesis , Metalloendopeptidases/genetics , Mice , Stromal Cells/enzymology , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-2/biosynthesis , Tissue Inhibitor of Metalloproteinase-2/genetics , Tumor Cells, Cultured
16.
Cancer Res ; 60(10): 2660-5, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10825138

ABSTRACT

The possibility to inhibit tumor growth by interfering with the formation of new vessels, which most neoplasias depend on, has recently raised considerable interest. An angiogenic switch, in which proliferating cells acquire the ability to direct new vessel formation, is thought to be an early step in the natural history of solid tumors. Using a transgenic model of breast cancer, which shows many similarities to its human counterpart, including ability to metastasize, we targeted angiostatin production to an early stage of tumor formation. Liposome-delivered angiostatin considerably delayed primary tumor growth and, more importantly, inhibited the appearance of lung metastases. These findings can be relevant to the design of therapeutic intervention in humans.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Liposomes , Mammary Neoplasms, Experimental/drug therapy , Neoplasm Metastasis/prevention & control , Peptide Fragments/administration & dosage , Peptide Fragments/therapeutic use , Plasminogen/administration & dosage , Plasminogen/therapeutic use , Angiostatins , Animals , Female , Genetic Therapy , Humans , Mammary Neoplasms, Experimental/pathology , Membrane Proteins/genetics , Mice , Mice, Transgenic , Receptor, ErbB-2/genetics , Receptors, Virus/genetics
17.
Clin Cancer Res ; 5(11): 3603-7, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10589777

ABSTRACT

Matrix metalloproteinases (MMPs) have been implicated in tumor cell invasion, metastasis, and angiogenesis. BAY 12-9566, a novel, non-peptidic biphenyl MMP inhibitor, has shown preclinical activity on a broad range of tumor models and is currently in clinical development. The purpose of this study was to investigate the antiangiogenic activity of BAY 12-9566. In vitro, BAY 12-9566 prevented matrix invasion by endothelial cells in a concentration-dependent manner (IC50 = 8.4x10(-7) M), without affecting cell proliferation. In vivo, oral daily administration of BAY 12-9566 (50-200 mg/kg) inhibited angiogenesis induced by basic fibroblast growth factor in the Matrigel plug assay, reducing the hemoglobin content of the pellets. Histological analysis showed a reduction in the amount of functional vessels within the Matrigel. We conclude that the MMP inhibitor BAY 12-9566 inhibits angiogenesis, a property that further supports its clinical development as an antimetastatic agent.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Endothelium, Vascular/physiology , Fibroblast Growth Factor 2/pharmacology , Matrix Metalloproteinase Inhibitors , Neovascularization, Pathologic/prevention & control , Neovascularization, Physiologic/drug effects , Organic Chemicals , Animals , Biphenyl Compounds , Cell Division/drug effects , Cells, Cultured , Collagen , Dose-Response Relationship, Drug , Drug Combinations , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Humans , Laminin , Mice , Mice, Inbred C57BL , Phenylbutyrates , Proteoglycans , Umbilical Veins
18.
Gene Ther ; 6(11): 1893-7, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10602385

ABSTRACT

Gene therapy approaches to the treatment of experimental cancer are usually based on established neoplastic cell lines which are manipulated in vitro and subsequently transplanted in host animals. However, the relevance of these artificial models to the biology and therapy of human tumors is uncertain. We have previously validated an experimental model based on MMTV-neu transgenic mice in which breast tumors arise spontaneously in 100% of animals and have many features in common with their human counterpart, including the involvement of the neu oncogene and the ability to metastatize. In this article we report the effect of intratumoral, retrovirus-mediated, IL-4 expression on the growth of breast tumors arising in these mice. The size of IL-4 inoculated tumors on the right side was significantly smaller than that of controlateral untreated tumors, suggesting a local effect of IL-4. In addition, the non-injected tumors on the left side of treated animals were significantly smaller than those arising in control transgenic mice, suggesting that IL-4 can also inhibit tumor growth systemically. These findings suggest that IL-4 gene transfer can significantly reduce the growth rate of spontaneously arising breast tumors and that immune-based gene therapy could efficiently complement other approaches based on different mechanisms, such as suicide gene transfer or antisense technology.


Subject(s)
Gene Transfer Techniques , Genetic Therapy/methods , Interleukin-4/genetics , Mammary Neoplasms, Animal/therapy , Animals , Breast Neoplasms/therapy , Female , Humans , Mice , Neoplasm Transplantation , Tumor Cells, Cultured
19.
Rays ; 23(2): 263-9, 1998.
Article in English, Italian | MEDLINE | ID: mdl-9689847

ABSTRACT

The "Policlinico A. Gemelli" in the context of ongoing change in the Italian Health Care Service, has developed a Strategic Plan for 1996-2000. In this context a major role is played by the reengineering project, divided into there sequential phases of implementation. The natural evolution of this project results in a department-oriented organization in order to complete and implement change.


Subject(s)
Hospital Restructuring/organization & administration , Hospitals, Teaching/organization & administration , Cost Control , Efficiency, Organizational , Health Care Reform , Health Priorities , Hospital Departments/economics , Hospital Departments/organization & administration , Hospital Restructuring/economics , Hospitals, Teaching/economics , Humans , Italy , Organizational Culture , Organizational Innovation , Organizational Objectives , Outcome and Process Assessment, Health Care , Patient-Centered Care , Planning Techniques , Quality of Health Care , State Medicine
20.
Rays ; 23(2): 288-94, 1998.
Article in English, Italian | MEDLINE | ID: mdl-9689849

ABSTRACT

Phase 2 of reengineering project, the testing of solutions, was based on the definition of a Prototype, and the implementation of the Pilot phase. This gradual process has facilitated the organizational change and laid the foundations of subsequent extension phase. Ongoing initiatives concern the introduction of two new centers (wards and outpatient service) and the reorganization of ward and operating room activities.


Subject(s)
Hospital Restructuring/organization & administration , Hospitals, Teaching/organization & administration , Appointments and Schedules , Diagnostic Services/organization & administration , Efficiency, Organizational , Health Plan Implementation , Hospital Units/organization & administration , Humans , Italy , Medical Staff, Hospital/organization & administration , Operating Rooms/organization & administration , Organizational Innovation , Organizational Objectives , Outcome and Process Assessment, Health Care , Outpatient Clinics, Hospital/organization & administration , Patient-Centered Care/organization & administration , Pilot Projects , Planning Techniques , Quality of Health Care
SELECTION OF CITATIONS
SEARCH DETAIL
...